Effects of PKCε knockdown on mitochondrial membrane potential of human glioma cells in vitro and growth of U251 cell-derived tumors in vivo

References

• Anjum K, Shagufta BI, Abbas SQ, Patel S, Khan I, Shah SAA, Akhter N, Hassan SSU. 2017. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: a review. Biomed Pharmacother. 92:681–689. doi: 10.1016/j.biopha.2017.05.125.
   PubMed Web of Science ®Google Scholar
• Bae KM, Wang H, Jiang G, Chen MG, Lu L, Xiao L. 2007. Protein kinase Cε is overexpressed in primary human non–small cell lung cancers and functionally required for proliferation of non–small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res. 67:6053–6063. doi: 10.1158/0008-5472.CAN-06-4037.
   PubMed Web of Science ®Google Scholar
• Basu A, Sivaprasad U. 2007. Protein kinase Cε makes the life and death decision. Cell Sign. 19:1633–1642. doi: 10.1016/j.cellsig.2007.04.008.
   PubMed Web of Science ®Google Scholar
• Bush NA, Chang SM, Berger MS. 2017. Current and future strategies for treatment of glioma. Neurosurg Rev. 40:1–14. doi: 10.1007/s10143-016-0709-8.
   PubMed Web of Science ®Google Scholar
• Caino MC, Lopez-Haber C, Kim J, Mochly-Rosen D, Kazanietz MG. 2012. Proteins kinase Cɛ is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes. Oncogene. 31:2593–2600. doi: 10.1038/onc.2011.428.
   PubMed Web of Science ®Google Scholar
• de Groot JF, Liu TJ, Fuller G, Yung WK. 2005. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res. 65:1934–1940. doi: 10.1158/0008-5472.CAN-04-3626.
   PubMed Web of Science ®Google Scholar
• Farah CA, Sossin WS. 2012. The role of C2 domains in PKC signalling. Adv Exp Med Biol. 740:663–683.
   PubMed Web of Science ®Google Scholar
• Furnari FB, Lin H, Huang HS, Cavenee WK. 1997. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA. 94:12479–12484. doi: 10.1073/pnas.94.23.12479.
   PubMed Web of Science ®Google Scholar
• Garg R, Benedetti LG, Abera MB, Wang H, Abba M, Kazanietz MG. 2014. Protein kinase C and cancer: what we know and what we do not. Oncogene. 33:5225–5237. doi: 10.1038/onc.2013.524.
   PubMed Web of Science ®Google Scholar
• Gorin MA, Pan Q. 2009. Protein kinase Cε: an oncogene and emerging tumor biomarker. Mol Cancer. 8:9. doi: 10.1186/1476-4598-8-9.
   PubMed Web of Science ®Google Scholar
• Huang B, Cao K, Li X, Guo S, Mao X, Wang Z, Zhuang J, Pan J, Mo C, Chen J, Qiu S. 2011. The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma. J Exp Clin Cancer Res. 30:88. doi: 10.1186/1756-9966-30-88.
   PubMed Web of Science ®Google Scholar
• Isakov N. 2018. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression. Sem Cancer Biol. 48:36–52. doi: 10.1016/j.semcancer.2017.04.012.
   PubMed Web of Science ®Google Scholar
• Jain K, Basu A. 2014. The multifunctional protein kinase C-ε in cancer development and progression. Cancers (Basel). 6:860–878. doi: 10.3390/cancers6020860.
   PubMed Web of Science ®Google Scholar
• Liu TJ, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL. 1999. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines. Cancer Gene Ther. 6:163–171. doi: 10.1038/sj.cgt.7700007.
   PubMed Web of Science ®Google Scholar
• Ly JD, Grubb DR, Lawen A. 2003. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 8:115–128. doi: 10.1023/A:1022945107762.
   PubMed Web of Science ®Google Scholar
• Molinaro AM, Taylor JW, Wiencke JK, Wrensch MR. 2019. Genetic and molecular epidemiology of adult diffuse glioma. Nat Rev Neurol. 15:405–417. doi: 10.1038/s41582-019-0220-2.
   PubMed Web of Science ®Google Scholar
• Newton AC. 2003. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J. 370:361–371. doi: 10.1042/bj20021626.
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:484–496. doi: 10.1096/fasebj.9.7.7737456.
   PubMed Web of Science ®Google Scholar
• Omuro A, DeAngelis LM. 2013. Glioblastoma and other malignant gliomas: a clinical review. J Am Med Assoc. 310:1842–1850. doi: 10.1001/jama.2013.280319.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. 2019. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro Oncol. 21:v1–v100. doi: 10.1093/neuonc/noz150.
   PubMed Web of Science ®Google Scholar
• Park CM, Park MJ, Kwak HJ, Lee HC, Kim MS, Lee SH, Park IC, Rhee CH, Hong SI. 2006. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor–mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res. 66:8511–8519. doi: 10.1158/0008-5472.CAN-05-4340.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual. New York: C S Harb, Press.
   Google Scholar
• Taylor LP. 2010. Diagnosis, treatment, and prognosis of glioma: five new things. Neurology. 75:S28–S32. doi: 10.1212/WNL.0b013e3181fb3661.
   PubMed Web of Science ®Google Scholar
• Toton E, Ignatowicz E, Skrzeczkowska K, Rybczynska M. 2011. Protein kinase Cε as a cancer marker and target for anticancer therapy. Pharmacol Rep. 63:19–29. doi: 10.1016/S1734-1140(11)70395-4.
   PubMed Web of Science ®Google Scholar
• Wesseling P, Capper D. 2018. WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol. 44:139–150. doi: 10.1111/nan.12432.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li Z, Zhang C, Zhang S, Ji Y, Chen F. 2015. Knockdown of PKCε expression inhibits growth, induces apoptosis and decreases invasiveness of human glioma cells partially through Stat3. J Mol Neurosci. 55:21–31. doi: 10.1007/s12031-014-0341-4.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xiang W, Yi DY, Xue BZ, Wen WW, Abdelmaksoud A, Xiong NX, Jiang XB, Zhao HY, Fu P. 2018. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas. Stem Cell Res Ther. 9:228. doi: 10.1186/s13287-018-0977-z.
   PubMed Web of Science ®Google Scholar
• Zhao M, Mydlarz WK, Zhou S, Califano J. 2008. Head and neck cancer cell lines are resistant to mitochondrial-depolarization-induced apoptosis. J Otorhinolaryngol Rel Spec. 70:257–263. doi: 10.1159/000133280.
   PubMedGoogle Scholar